recompense but a satisfaction or putting right, and sometimes may include disciplinary action. It seems, from letters received from patients, that part of a patient's shock after such an accident stems directly from the injury received with its attendant pain or disability, but a large part is rooted in the wall of non-communication which replaces the previous concern for the patient's welfare. Just when a patient has suffered a major loss, he or she finds that the nursing and medical staff have no more to say. They may even become unpleasant. The desirability of expressing to the patient an attitude of sympathy and reassurance in such circumstances was emphasized. Though sympathetic treatment by doctors merely to head off possibly justified claims of negligence is certainly not condoned, some unnecessary legal proceedings might be avoided by a little time and effort being spent with a patient, acknowledging and explaining the problems of the case. Doctors find this very difficult because of their concern that their comments may be construed as evidence against colleagues, and yet the person in the position to help at that stage is the doctor. It is unacceptable that patients suffering injury at the hands of the medical profession should then be estranged by the profession.
The introduction of the no-fault compensation system may prove to be a major step forward, but, in the meantime, a different approach to patients who have suffered through negligence must be developed as-a matter of the highest priority.
FIONA CAITHNESS
Research Assistant CANTAB Group, Cambridgeshire
Section of Rheumatology & Rehabilitation: short papers'
The meeting opened with a paper on primary multifocal fibrositis and chronic benzodiazepine consumption, read by T Bitter for M Waidburger (Switzerland). Smyth (1981) proposed diagnostic criteria for the 'fibrositis syndrome' to include widespread aching pain which is burning in character and unrelieved by non-steroidal antiinflammatory drugs, diffuse local tenderness often at musculotendinous insertions and disturbance of the sleep pattern. In this limited study of 27 women presenting with this syndrome, 25 had been taking benzodiazepines (diazepam being the most well-known example) for up to 15 years. It is suggested that prolonged treatment with these drugs lowers the pain threshold, possibly by depletion of brain serotonin (Snyders et al. 1977) , with resulting depression of the stage IV (nonrapid-eye-movement) sleep pattern. From the audience, Dr A Crisp wondered whether hormonal replacement might help, as most of the women in the study were perimenopausal; this did not appear to be the case.
Dr T R Littler spoke for K R H Adams and L D C Halliday (Liverpool) on their experience with etretinate in polyarthritis and psoriasis. Etretinate is a synthetic derivative of vitamin A with similar biological activity and relatively less toxicity. In view of its known beneficial effect on psoriasis, and because retinol can affect mesenchymal as well as epithelial cells, its possible value in the treatment of psoriatic arthritis (5 patients), indeterminate seronegative arthritis with psoriasis (3 patients) and seropositive rheumatoid arthritis (2 patients) was studied. The dose was 50 mg daily for 2 months, then 25 mg daily for 4 months. The benefici4l effect of etretinate was confirmed. Encouraging results were also obtained in polyarthritis associated with psoriasis in the seronegative groups, but not in the seropositive rheumatoid patients. There were numerous side effects, especially cheilitis and hair loss. It was concluded that the drug could not be recommended for the treatment of polyarthritis with or without psoriasis in the dosage used in this study.
Dr T D Kennedy, for C S Higgins, D F Woodrow and J T Scott (London), gave a paper on crystal deposition in the knee and great toe joints of asymptomatic gout patients. Monosodium urate (MSU) crystals often remain in the synovial fluid or membrane long after an acute attack of gout has resolved (Scott 1978) . Crystals have been found in the synovial fluid of asymptomatic first metatarsophalangeal (MTP) joints (Weinberger et al. 1979) . In 31 patients with proven gout, arthroscopy of the knee (which had never been the site of acute gout) was performed. Crystalline material was seen in 9 (29%). Histology of the synovial membrane demonstrated MSU crystals in 3 and calcium pyrophosphate 'dihydrate (CPPD) crystals in one of the 31 biopsies studied. Synovial fluid was obtained from 27 of the knees; MSU crystals were seen in 4 (14%) and CPPD crystals in 2. Immediately following arthroscopy, the first MTP joint was aspirated. MSU crystals were demonstrated in 14 (52%) of the 27 samples 'Report of meeting of the Section of Rheumatology & Rehabilitation, 8 February 1984. Accepted 10 May 1984 obtained and CPPD crystals were not seen. The mean serum uric acid (SUA) was 424.5 pmol/l in patients with crystals and 338.3 pmol/l in 'crystalfree' patients (P <0.05). Twenty-three patients were receiving urate-lowering treatment; of these, 15 were 'crystal-free' and in the remaining 8 crystals were found. However, there was no significant difference in the SUA of the patients in this treated group. Eight patients were untreated and in all of these MSU crystals were observed. It is concluded that urate crystals may be present without initiating an acute attack of gout, and that finding them does not necessarily indicate a diagnosis of acute gout (Kennedy et al. 1984) .
Professor E G L Bywaters wondered if MSU crystals were first seen in the synovial membrane or the cartilage. Dr R Sturrock asked how MSU crystals could be asymptomatic; it was suggested that the crystals might be coated by protein so making them less phlogistic.
A paper on small bowel ulceration in rheumatoid arthritis as a cause of iron deficiency anaemia was presented by R Madhok for J MacKenzie, F D Lee and R D Sturrock (Glasgow). Three patients with rheumatoid arthritis taking non-steroidal anti-inflammatory drugs (NSAIDs) had recurrent gastrointestinal bleeding, which was due to superficial ulceration of the terminal ileum in two. The exact pathology of the condition was undetermined, though it was thought that the NSAIDs (including controlledrelease preparations) might be responsible, possibly due to loss of the cytoprotective effect of prostaglandins (PGE2 and PGI2) inhibited by NSAID therapy. Dr F Bruckner related how a patient so treated developed leukopenia and oral ulceration and then sudden haematemesis. Angiography showed that the bleeding originated from the small intestine. Dr V L Steinberg had a patient who developed severe ulceration of the small intestine while on phenylbutazone. Dr M E Shipley presented a paper describing a retrospective study of 82 patients undergoing total knee replacement arthroplasty (TKR), for R Q Crellin, E R Thomas and E B D Hamilton (London). Of 53 patients who had received total knee replacement, 44 were reviewed retrospectively at a mean follow up of 72 years; 8 patients had died. Of the 44 assessed, most acknowledged that the operation had reduced pain and improved mobility but complications were frequent, especially in the earlier cases before prophylactic antibiotic cover was used. Eight developed serious infection, leading to removal of the joint in 4 cases. Thirty patients were subsequently studied prospectively, with 21 being reviewed at a mean follow up of 3 to 5 years; 8 have died and one has emigrated. Of the 21 all but one experienced marked pain relief (16 out of 29 knees pain-free) and most were more mobile than before. Assessment of outcome is made difficult because generalized progressive rheumatoid arthritis leads to increasing pain and disability. Dr Swinson enquired whether arthroplasty reduced the incidence of synovitis in the operated knee, and it seemed likely that this was the case.
A paper on predictors of outcome at two years in patients with rheumatoid arthritis, was read by J Reeback for A J Silman (London). This prospective study of 72 patients seen within 18 months of onset of rheumatoid arthritis evaluated the use of clinical measures (e.g. age, sex, mode of onset, patient's and physician's assessment of disease activity, and articular index) and laboratory measures (e.g. erythrocyte sedimentation rate, C-reactive protein assay, latex titre and immune complexes) for predicting disease outcome after 2 years as assessed by deformity, limitation of wrist extension and functional ability measured using the Stanford Health Assessment Questionnaire (HAQ). It was found that restricted wrist extension was related to insidious onset of disease, high latex titre and high articular index at the first visit, whereas poor functional capacity as measured by the Stanford HAQ was associated with a high initial articular index and a high latex titre. Neither outcome was associated with the initial level of acute phase reactants nor with patient's or physician's initial assessment of disease activity (Reeback & Silman 1984) .
Dr M Grayson asked why wrist extension was chosen as the measure of disability: this was because many rheumatologists feel that poor wrist extension relates to severe disease, and that no patient cooperation is required for this test. In reply to a question from Dr R Sturrock it was stated that there was no correlation with secondline anti-rheumatic drug therapy. Dr J Glynn asked what question was posed to ascertain the patients' assessment of their own disease activity. This was: 'How bad is your joint disease?' In view of the apparent frequency of arthritis confined to the wrists in seronegative arthritis, Dr Shipley enquired whether seronegative arthritis had been found to be associated with poor wrist extension, but this had not been the case.
Dr C Chattopadhyay for D R Swinson (Wigan), presented a paper describing a study of radiological progression of rheumatoid arthritis in a placebo-controlled trial of sulphasalazine. Twenty-three rheumatoid patients on sulphasalazine and an equal number on placebo treatment completed a 6-month double-blind study; 16 of the placebo group started on sulphasalazine or another second-line drug at 26 weeks. At the end of the study X-rays of hands and feet were read by 'blind' observers. Both treated groups showed a similar degree of radiological deterioration, but the placebo group deteriorated significantly whereas the treated group did not. There was no correlation between the initial rheumatoid activity and subsequent development of new erosions. Dr M Corbett enquired about the duration of rheumatoid diseasethis was 3 to 5 years. Dr H Berry suggested that the study ought to have been prolonged for another 3 months to cover the latent period before second-line drug activity became manifest.
Dr A N Bamji for R J Berry and B Windeyer (London), reported a long-term follow-up study of the treatment of ankylosing spondylitis (AS) with radiotherapy. Radiotherapy of AS fell out of fashion for two reasons: the efficacy of nonsteroidal anti-inflammatory drugs and the dangers of leukaemia or aplastic anaemia and increased risk of cancer following radiotherapy. Forty-eight patients with AS were selected from 1500 given radiotherapy between 1943 and 1983. The diagnosis was felt to be doubtful (i.e. could have been another type of seronegative spondylitis) in 6 of the pre-1960 and one post-1960 treated patients. There was a good response to therapy in 45 of 59 courses of radiotherapy in the pre-1960 group and late perception of long-term improvement in 24 of the 29 patients. The frequency of skin cancer (which was not dosedependent) was 24%. It could not be shown that radiotherapy favourably altered the spinal X-ray changes. Dr F D Hart enquired about the dosage used: this was between 1200 and 2400 rad per session. Dr J Glynn wanted to know whether certain types of seronegative spondarthritis, such as those associated with Reiter's disease, responded to radiotherapy and it appeared this was often so. In reply to Dr G Hughes it seemed that radiotherapy was sometimes helpful in patients with AS who proved intractable to standard drug therapy.
D N GOLDING

Editorial Representative Section of Rheumatology & Rehabilitation
Lipids in clinical medicine'
The Society's Forum on Lipids in Clinical Medicine was launched on 16 March 1984. The purpose of the Forum is to encourage the interdisciplinary approach by bringing together physicians, biochemists, epidemiologists, nutritionists and others with an active medical interest in lipids who wish to keep abreast of thinking and developments in the other specialties. The programme of this inaugural meeting covered a broad range of topical issues by way of introduction.
Dr Ingvar Hjermann (Oslo) and Mr Robert Duffield (London) presented evidence from their own epidemiological and clinical studies for a beneficial effect of reduction of plasma lipid concentrations in hypercholesterolaemic men (Hjermann et al. 1981 , Duffield et da 1983 . In Oslo, repeated encouragement given to the intervention group to reduce dietary saturated fat intake, increase polyunsaturated fat consumption and (when hypertriglyceridaemia was also present) to lower total energy intake, together with discouragement of smoking, achieved a 47% reduction in fatal and non-fatal coronary heart disease (CHD) over 5 years as compared to controls. Most of this reduction appeared due to a decrease in serum cholesterol and fasting triglyceride, which were 13% and 20% lower in the intervention groups at 5 years. In both intervention and control groups a significant inverse relation was found between reduction in serum cholesterol (as a proportion of concentration at recruitment) and CHD incidence. Counselling given to smokers met with relatively little success, and what effect was achieved was insufficient to have had any statistically significant benefit on CHD risk.
Encouraging results have been obtained in several studies in which changes in the arteriogram were used as a measure of efficacy of lipidlowering therapy in hypercholesterolaemic adults. To be of any value, such investigations demand sophisticated techniques, considerable expertise 'Report of the inaugural meeting of the Forum on Lipids in Clinical Medicine, 16 March 1984 . Accepted 20 June 1984 
